HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Young Hyun Yu Selected Research

physciosporin

10/2021Physciosporin suppresses mitochondrial respiration, aerobic glycolysis, and tumorigenesis in breast cancer.
2/2021Corrigendum to: 'Physciosporin suppresses the proliferation, motility and tumorigenesis of colorectal cancer cells' Phytomedicine 56 (2019) 10-20.
3/2019Physciosporin suppresses the proliferation, motility and tumourigenesis of colorectal cancer cells.
1/2015Lichen Secondary Metabolite, Physciosporin, Inhibits Lung Cancer Cell Motility.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Young Hyun Yu Research Topics

Disease

5Neoplasms (Cancer)
10/2021 - 01/2016
5Neoplasm Metastasis (Metastasis)
01/2021 - 01/2015
4Colorectal Neoplasms (Colorectal Cancer)
02/2021 - 11/2018
2Carcinogenesis
10/2021 - 02/2021
2Lung Neoplasms (Lung Cancer)
03/2019 - 01/2015
1Breast Neoplasms (Breast Cancer)
10/2021
1Tics (Tic)
01/2019
1Glioma (Gliomas)
11/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2016

Drug/Important Bio-Agent (IBA)

4physciosporinIBA
10/2021 - 01/2015
2AcetoneIBA
11/2018 - 01/2015
2usnic acidIBA
11/2018 - 01/2016
1Estrogens (Estrogen)FDA Link
10/2021
1CateninsIBA
10/2021
1ProgesteroneFDA LinkGeneric
10/2021
1Pharmaceutical PreparationsIBA
01/2021
1Fluorouracil (Carac)FDA LinkGeneric
01/2021
1AntibodiesIBA
01/2019
1Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA
01/2019
1LigandsIBA
01/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1Proteins (Proteins, Gene)FDA Link
11/2018
1AldehydesIBA
11/2018
1Messenger RNA (mRNA)IBA
11/2018
1PotassiumIBA
11/2018
1SaltsIBA
11/2018

Therapy/Procedure

2Therapeutics
01/2019 - 01/2016
1Oral Administration
11/2018